FEDORA: A phase II study to evaluate the safety, toxicity and tolerability of the combination of fedratinib and ropeginterferon alfa-2b, in patients with myelofibrosis

  • Fox, Sonia (Co-Investigator)
  • Craddock, Charles (Researcher)
  • Jackson, Aimee (Principal Investigator)

Project Details

Short titleFEDORA: A phase II study to evaluate the safety, toxicity and tolerability of the combination of fedratinib and ropeginterferon alfa-2b, in patients with myelofibrosis
StatusActive
Effective start/end date31/12/21 → 30/06/26

Funding

  • AOP Orphan Pharmaceuticals GmbH